 Cristina Penaranda
Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 4 | 2026 | 356 | 1.580 |
Why?
| | Host-Pathogen Interactions | 4 | 2021 | 371 | 1.200 |
Why?
| | Pseudomonas Infections | 3 | 2026 | 221 | 1.080 |
Why?
| | Genome, Bacterial | 2 | 2026 | 156 | 0.990 |
Why?
| | Bacterial Infections | 2 | 2019 | 246 | 0.530 |
Why?
| | Adaptation, Physiological | 1 | 2021 | 570 | 0.500 |
Why?
| | T-Lymphocytes, Regulatory | 4 | 2011 | 389 | 0.460 |
Why?
| | Islets of Langerhans | 3 | 2010 | 833 | 0.440 |
Why?
| | Immune Tolerance | 3 | 2012 | 379 | 0.380 |
Why?
| | Immunologic Memory | 2 | 2012 | 366 | 0.370 |
Why?
| | Receptors, Interleukin-7 | 1 | 2012 | 28 | 0.370 |
Why?
| | Interleukin-7 | 1 | 2012 | 65 | 0.360 |
Why?
| | Bacteria | 1 | 2019 | 889 | 0.360 |
Why?
| | Diabetes Mellitus, Type 1 | 5 | 2012 | 3890 | 0.350 |
Why?
| | CD3 Complex | 1 | 2011 | 111 | 0.330 |
Why?
| | Lymphocyte Depletion | 1 | 2011 | 132 | 0.330 |
Why?
| | T-Lymphocyte Subsets | 2 | 2011 | 415 | 0.330 |
Why?
| | Propylene Glycols | 1 | 2010 | 27 | 0.310 |
Why?
| | Sphingosine | 1 | 2010 | 45 | 0.310 |
Why?
| | T-Lymphocytes | 4 | 2014 | 1982 | 0.290 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2009 | 668 | 0.250 |
Why?
| | Mice, Inbred NOD | 5 | 2012 | 610 | 0.250 |
Why?
| | Autoimmunity | 2 | 2009 | 927 | 0.240 |
Why?
| | Environmental Microbiology | 1 | 2026 | 57 | 0.230 |
Why?
| | Immunosuppressive Agents | 1 | 2010 | 847 | 0.220 |
Why?
| | Virulence | 1 | 2026 | 280 | 0.220 |
Why?
| | Whole Genome Sequencing | 1 | 2026 | 183 | 0.220 |
Why?
| | Drug Resistance, Bacterial | 1 | 2026 | 199 | 0.210 |
Why?
| | Virulence Factors | 1 | 2026 | 174 | 0.210 |
Why?
| | Antibodies, Monoclonal | 1 | 2011 | 1524 | 0.200 |
Why?
| | Mice | 13 | 2021 | 18365 | 0.200 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1786 | 0.200 |
Why?
| | Biofilms | 1 | 2026 | 278 | 0.190 |
Why?
| | Animals | 18 | 2021 | 38109 | 0.190 |
Why?
| | Receptor, IGF Type 1 | 3 | 2007 | 64 | 0.180 |
Why?
| | Signal Transduction | 3 | 2012 | 5233 | 0.170 |
Why?
| | Diabetes Mellitus | 1 | 2010 | 1098 | 0.170 |
Why?
| | Intracellular Space | 1 | 2021 | 66 | 0.170 |
Why?
| | Microbial Viability | 1 | 2021 | 90 | 0.160 |
Why?
| | Genetic Variation | 1 | 2026 | 984 | 0.160 |
Why?
| | Genetic Fitness | 1 | 2021 | 59 | 0.160 |
Why?
| | Genomics | 1 | 2026 | 836 | 0.160 |
Why?
| | Bacterial Proteins | 1 | 2026 | 962 | 0.150 |
Why?
| | Interferon-gamma | 4 | 2014 | 784 | 0.140 |
Why?
| | Genome-Wide Association Study | 1 | 2026 | 1407 | 0.140 |
Why?
| | Chimera | 1 | 2018 | 61 | 0.140 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2021 | 328 | 0.140 |
Why?
| | RNA, Bacterial | 1 | 2019 | 189 | 0.140 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 203 | 0.140 |
Why?
| | Host-Parasite Interactions | 1 | 2019 | 112 | 0.140 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2019 | 60 | 0.140 |
Why?
| | Embryo, Nonmammalian | 1 | 2018 | 173 | 0.140 |
Why?
| | Embryo, Mammalian | 1 | 2018 | 232 | 0.130 |
Why?
| | Phenotype | 1 | 2026 | 3164 | 0.130 |
Why?
| | Hematopoiesis | 1 | 2018 | 194 | 0.130 |
Why?
| | Mice, Transgenic | 4 | 2011 | 2185 | 0.130 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5997 | 0.120 |
Why?
| | Masoprocol | 2 | 2007 | 3 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 442 | 0.120 |
Why?
| | Tuberculosis | 1 | 2019 | 291 | 0.120 |
Why?
| | Lymphocyte Activation | 3 | 2012 | 1126 | 0.120 |
Why?
| | Mycobacterium tuberculosis | 1 | 2019 | 337 | 0.120 |
Why?
| | Urea | 2 | 2006 | 84 | 0.120 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 359 | 0.110 |
Why?
| | Cells, Cultured | 2 | 2021 | 4155 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2026 | 1915 | 0.110 |
Why?
| | Adoptive Transfer | 2 | 2012 | 198 | 0.110 |
Why?
| | Zebrafish | 1 | 2018 | 528 | 0.100 |
Why?
| | Salmonella typhimurium | 1 | 2015 | 190 | 0.100 |
Why?
| | Galactosylceramides | 1 | 2013 | 27 | 0.100 |
Why?
| | Bacteroides fragilis | 1 | 2013 | 14 | 0.100 |
Why?
| | DNA-Binding Proteins | 2 | 2011 | 1500 | 0.100 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2012 | 264 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2010 | 1129 | 0.090 |
Why?
| | Regeneration | 1 | 2014 | 197 | 0.090 |
Why?
| | Antigens, Differentiation | 1 | 2012 | 77 | 0.090 |
Why?
| | Transcriptome | 1 | 2019 | 1046 | 0.090 |
Why?
| | Macrophages | 3 | 2015 | 1511 | 0.090 |
Why?
| | Pancreas | 1 | 2014 | 342 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2019 | 2832 | 0.090 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1253 | 0.080 |
Why?
| | Interleukin-2 | 2 | 2009 | 437 | 0.080 |
Why?
| | Thymus Gland | 1 | 2011 | 311 | 0.080 |
Why?
| | Fingolimod Hydrochloride | 1 | 2010 | 39 | 0.080 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2011 | 198 | 0.080 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 463 | 0.080 |
Why?
| | Transcription Factors | 2 | 2011 | 1742 | 0.080 |
Why?
| | Forkhead Transcription Factors | 1 | 2009 | 202 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 846 | 0.070 |
Why?
| | Lymphocytes | 1 | 2010 | 382 | 0.070 |
Why?
| | Graft Rejection | 1 | 2011 | 540 | 0.070 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2007 | 34 | 0.060 |
Why?
| | Humans | 9 | 2026 | 144957 | 0.060 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2006 | 17 | 0.060 |
Why?
| | Autoantigens | 1 | 2009 | 429 | 0.060 |
Why?
| | Aminoquinolines | 1 | 2006 | 18 | 0.060 |
Why?
| | Immunotherapy | 1 | 2011 | 657 | 0.060 |
Why?
| | Cell Line | 1 | 2011 | 2882 | 0.060 |
Why?
| | Phenylurea Compounds | 1 | 2006 | 112 | 0.060 |
Why?
| | Breast Neoplasms | 3 | 2007 | 2456 | 0.050 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2005 | 319 | 0.050 |
Why?
| | Mice, Knockout | 1 | 2010 | 3125 | 0.050 |
Why?
| | Female | 5 | 2021 | 78376 | 0.050 |
Why?
| | Apoptosis | 2 | 2006 | 2430 | 0.040 |
Why?
| | Protein Kinase Inhibitors | 1 | 2006 | 970 | 0.040 |
Why?
| | Dendritic Cells | 1 | 2003 | 499 | 0.040 |
Why?
| | Nucleic Acid Hybridization | 1 | 2019 | 187 | 0.040 |
Why?
| | Genes, Essential | 1 | 2019 | 21 | 0.040 |
Why?
| | Blastula | 1 | 2018 | 3 | 0.040 |
Why?
| | Cell Fusion | 1 | 2018 | 49 | 0.040 |
Why?
| | Cell Tracking | 1 | 2018 | 19 | 0.040 |
Why?
| | Coloring Agents | 1 | 2018 | 93 | 0.040 |
Why?
| | DNA Transposable Elements | 1 | 2019 | 122 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 194 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2005 | 2499 | 0.030 |
Why?
| | Larva | 1 | 2018 | 242 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2018 | 148 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 2018 | 294 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2018 | 320 | 0.030 |
Why?
| | Cell Lineage | 1 | 2018 | 376 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 58 | 0.030 |
Why?
| | Neoplasms | 1 | 2011 | 2884 | 0.030 |
Why?
| | Salmonella Infections | 1 | 2015 | 60 | 0.030 |
Why?
| | Ceruletide | 1 | 2014 | 4 | 0.030 |
Why?
| | Models, Statistical | 1 | 2019 | 682 | 0.030 |
Why?
| | Acinar Cells | 1 | 2014 | 13 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2006 | 2197 | 0.030 |
Why?
| | Cell Dedifferentiation | 1 | 2014 | 32 | 0.030 |
Why?
| | Interferon Type I | 1 | 2015 | 145 | 0.030 |
Why?
| | Cell Line, Tumor | 3 | 2007 | 3550 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2014 | 162 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 965 | 0.030 |
Why?
| | Macrophage Activation | 1 | 2014 | 193 | 0.020 |
Why?
| | Young Adult | 1 | 2010 | 14126 | 0.020 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 67 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2015 | 863 | 0.020 |
Why?
| | Receptor Cross-Talk | 1 | 2011 | 21 | 0.020 |
Why?
| | CD28 Antigens | 1 | 2011 | 58 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2011 | 55 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 160 | 0.020 |
Why?
| | CTLA-4 Antigen | 1 | 2011 | 104 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 187 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2014 | 524 | 0.020 |
Why?
| | Adolescent | 1 | 2010 | 22453 | 0.020 |
Why?
| | Child | 1 | 2010 | 22657 | 0.020 |
Why?
| | Complementarity Determining Regions | 1 | 2009 | 53 | 0.020 |
Why?
| | CpG Islands | 1 | 2009 | 165 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2014 | 877 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2009 | 118 | 0.020 |
Why?
| | Luminescent Proteins | 1 | 2009 | 185 | 0.020 |
Why?
| | Neutrophils | 1 | 2014 | 1134 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2009 | 322 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 80 | 0.020 |
Why?
| | Antigens, CD | 1 | 2011 | 555 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 241 | 0.020 |
Why?
| | Cricetulus | 1 | 2006 | 118 | 0.020 |
Why?
| | CHO Cells | 1 | 2006 | 171 | 0.020 |
Why?
| | Cricetinae | 1 | 2006 | 304 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 2009 | 420 | 0.010 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2006 | 70 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 2157 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2008 | 502 | 0.010 |
Why?
| | Animals, Genetically Modified | 1 | 2006 | 250 | 0.010 |
Why?
| | Caspases | 1 | 2006 | 232 | 0.010 |
Why?
| | Cell Survival | 1 | 2008 | 1098 | 0.010 |
Why?
| | Neoplasms, Experimental | 1 | 2005 | 173 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2931 | 0.010 |
Why?
| | Cell Division | 1 | 2006 | 766 | 0.010 |
Why?
| | DNA Methylation | 1 | 2009 | 683 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2003 | 124 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2003 | 156 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2005 | 1311 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2880 | 0.010 |
Why?
| | T-Box Domain Proteins | 1 | 2003 | 106 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 161 | 0.010 |
Why?
| | Mutation | 1 | 2013 | 4099 | 0.010 |
Why?
| | Antigens | 1 | 2003 | 347 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1733 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 983 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 851 | 0.010 |
Why?
| | Blotting, Western | 1 | 2003 | 1187 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 852 | 0.010 |
Why?
| | Time Factors | 1 | 2003 | 7183 | 0.010 |
Why?
| | Male | 1 | 2018 | 72406 | 0.010 |
Why?
|
|
Penaranda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|